In line with this assumption, evaluation of LCIS lesions demonstrated that E-cadherin-negative pre-invasive tumor cells rather exhibit a reduced, but not an increased, BCL2 immunoreactivity, when compared with the adjacent normal epithelium. This evidence concerns the gene BCL2 and neoplasm.